Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novoste Holding Line Against Guidant In Coronary Brachytherapy Market

This article was originally published in The Gray Sheet

Executive Summary

Novoste says its recall of 50 Beta-Cath brachytherapy transfer units due to incorrect calibration will contribute to a modest sales decline during the current quarter versus the fourth quarter of 2001
Advertisement

Related Content

Novoste Beta-Cath
Novoste Beta-Cath
Guidant Galileo Expanded Intravascular Radiation Indications Slated For 2002
Guidant Galileo Expanded Intravascular Radiation Indications Slated For 2002
Advertisement
UsernamePublicRestriction

Register

MT016057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel